Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes

MLA

Alves de Inda, M., et al. “Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for Its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes.” Alves de Inda , M , van Strijp , D , Den Biezen-Timmermans , E , van Brussel , A , Wrobel , J , van Zon , H , Vos , P , Baillie , GS , Tennstedt , P , Schlomm , T , Houslay , MD , Bangma , C H & Hoffmann , R 2018 , ’ Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for Its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes ’ , European Urology Focus , Vol. 4 , No. 3 , Pp. 376-384 , 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1313624900&authtype=sso&custid=ns315887.

APA

Alves de Inda, M., van Strijp, D., den Biezen-Timmermans, E., van Brussel, A., Wrobel, J., van Zon, H., Vos, P., Baillie, G., Tennstedt, P., Schlomm, T., Houslay, M., Bangma, C. H., & Hoffmann, R. (2018). Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes. Alves de Inda , M , van Strijp , D , Den Biezen-Timmermans , E , van Brussel , A , Wrobel , J , van Zon , H , Vos , P , Baillie , GS , Tennstedt , P , Schlomm , T , Houslay , MD , Bangma , C H & Hoffmann , R 2018 , ’ Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for Its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes ’ , European Urology Focus , Vol. 4 , No. 3 , Pp. 376-384 .

Chicago

Alves de Inda, M, D van Strijp, E den Biezen-Timmermans, A van Brussel, J Wrobel, H van Zon, P Vos, et al. 2018. “Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for Its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes.” Alves de Inda , M , van Strijp , D , Den Biezen-Timmermans , E , van Brussel , A , Wrobel , J , van Zon , H , Vos , P , Baillie , GS , Tennstedt , P , Schlomm , T , Houslay , MD , Bangma , C H & Hoffmann , R 2018 , ’ Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for Its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes ’ , European Urology Focus , Vol. 4 , No. 3 , Pp. 376-384 . http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1313624900&authtype=sso&custid=ns315887.